Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study
about
Distribution of serotonin 5-HT2C receptors in the ventral tegmental areaGrowth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3)Environmental and Pharmacological Modulation of Amphetamine- Induced 50-kHz Ultrasonic Vocalizations in RatsA neural correlate of predicted and actual reward-value information in monkey pedunculopontine tegmental and dorsal raphe nucleus during saccade tasksSerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderStructure and function of serotonin G protein-coupled receptors.Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway functionSerotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy.Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female ratsImpact of RNA editing on functions of the serotonin 2C receptor in vivo5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathwayThe serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeysThe serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Serotonin receptor 2C and insulin secretionDissociable effects of 5-HT2C receptor antagonism and genetic inactivation on perseverance and learned non-reward in an egocentric spatial reversal task.How Adaptive Trial Designs can Increase Efficiency in Psychiatric Drug Development: A Case Study.Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in ratsDrug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophreniaOptimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.The effects of pharmacological modulation of the serotonin 2C receptor on goal-directed behavior in miceMolecular and behavioral pharmacology of two novel orally-active 5HT2 modulators: potential utility as antipsychotic medications.The role of the dorsal raphé nucleus in reward-seeking behaviorA novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.5-HT2 ligands in the treatment of anxiety and depression.Potential drug targets and treatment of schizophrenia.Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.Role of 5-hydroxytryptamine2C receptors in Ca2+-dependent ethanol potentiation of GABA release onto ventral tegmental area dopamine neurons.Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex.Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.Activation of 5-HT2A receptor disrupts rat maternal behavior.5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.Critical involvement of 5-HT2C receptor function in amphetamine-induced 50-kHz ultrasonic vocalizations in rats.Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain.
P2860
Q24682104-4BEAE7FE-35E8-4F32-AA98-1739549459FFQ26783258-DA1633AB-680F-4CF5-AD9F-7B72296CA0B7Q26786488-FADD406E-C73F-479D-8981-B75DBDA55C1FQ26827751-33916C1D-DC1D-4080-990E-34C3DA4524E8Q27015917-D27587DE-0536-4820-AD25-9BEF17A83F83Q30382524-C76D05EF-4A74-4D14-A970-62188D00E01AQ30387361-FB395B11-8E2B-4D28-BA33-7720E0BACA97Q30493133-BD29F649-96E3-4C14-ADD1-37CCACA09FD5Q30493995-E1758EE9-957E-4619-B9C3-0DF945D844C0Q30499670-78792046-9C69-4104-B83E-0DC9D6FD4D38Q30663345-C30E7E99-BC9A-40BD-B3DB-DEF981ADAAD7Q33667703-98F7FB40-D95D-4B04-A509-BAFA4F46A41DQ33806232-2AFE1296-24A1-416E-AD4C-51DE8CD0214FQ33936895-4AD6298C-74FB-4AD5-9252-2F156258D5ECQ34280398-46C31C3B-6FED-4E43-B207-1CDA8C0811C3Q34546304-C2F677F6-FA2F-4469-B146-503BBB5BD682Q34562833-14010A06-E247-470B-AAC4-907B9D731928Q35035586-50775FF3-AA6A-41B4-BDDA-16E4D230A786Q35174992-C37B2A46-12A9-4F9A-870B-11F8FA977D34Q35913179-E0A325A8-8AF3-42A3-97C7-5BF3AF33A1A2Q35952202-38D7CBE1-B719-44A0-9CC8-8EB77F42318AQ36584779-EDF08DF9-92CD-431B-A579-5D8C1C669FC8Q36805380-BA6D2FB8-6E6E-4D12-8FE6-5777FAC41FBEQ36930837-E0E1B778-986B-4E08-BF81-AB530D6FE41FQ36966228-8775709E-61CD-463C-9407-EB26707D51EDQ37121500-285E7EDA-3CB1-450F-A130-54500C8E6278Q37707718-122E9FB5-9C06-4249-832D-9F0FA6127606Q37826638-C5D712A6-DD30-4CC5-8354-F97FCDA8D52CQ38037141-4BB07EF7-E71E-46D2-A891-C78224CCBAB3Q39206300-284BE87C-6DC7-46EC-A7B4-B4E2764EAA6CQ41876191-72D4C59B-DCEE-4ACA-8D8D-F4DA981A1547Q42176852-89301B1C-2B0F-45F4-9375-7CE0C76E41D3Q42523067-40A399CB-0B51-4E87-A7E4-B39CC0CF71DAQ44297165-50A32BB5-F076-438E-B7D0-ADD725F9CAE4Q46240693-220D2D63-1098-4320-B40C-7FF5B45C0577Q47317394-2DABB83F-6D0E-40EC-9EB1-462D21B4B384Q47357220-5B5CDBCB-F6F9-43D6-A7C1-45FBD39812C2Q47786557-3C0E8058-10B9-4831-ADE1-4346D6E3038AQ47825190-96F37ED8-FA43-4C75-B3CF-539E94CC9047Q48250330-014E7D07-A1D9-423E-B636-379AE56CA460
P2860
Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Preferential modulation of mes ...... ogical and microdialysis study
@ast
Preferential modulation of mes ...... ogical and microdialysis study
@en
Preferential modulation of mes ...... ogical and microdialysis study
@nl
type
label
Preferential modulation of mes ...... ogical and microdialysis study
@ast
Preferential modulation of mes ...... ogical and microdialysis study
@en
Preferential modulation of mes ...... ogical and microdialysis study
@nl
prefLabel
Preferential modulation of mes ...... ogical and microdialysis study
@ast
Preferential modulation of mes ...... ogical and microdialysis study
@en
Preferential modulation of mes ...... ogical and microdialysis study
@nl
P2093
P2860
P921
P1433
P1476
Preferential modulation of mes ...... ogical and microdialysis study
@en
P2093
E Esposito
G Di Giovanni
M Di Mascio
V Di Matteo
P2860
P356
10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2
P407
P577
2000-01-01T00:00:00Z